Next Generation Blood Testing

Ultimate compatibility.

Maximal sustainability.


ELISA microplate
Innobiochips logo

High Definition Diagnostic Solutions for Precision Medicine

Driven by its unique expertise in biology and biochemistry, Innobiochips develops breakthrough solutions that significantly improve the accuracy and productivity of in vitro diagnostic approaches.

15 employees

10 years of ISO 13485 certification

3 CE marked solutions developed

1M biological tests produced a year and sold all over the world

More about Innobiochips

Building the most advanced diagnosis technology

Picto Transplantation


Transplantation is a critical treatment that faces many challenges to ensure perfect donor/recipient compatibility. Innobiochips has adapted its Siryus technology to offer a novel solution to assess the recipient's reaction to their transplant in order to drastically reduce rejection.


Picto Transfusion


Blood grouping approaches have not evolved in years. The process remains highly repetitive and resource intensive. Innobiochips will introduce a next-generation blood testing and grouping solution in 2024: Omnys. Based on breakthrough technologies, Omnys enables high-resolution testing of blood components: Standard ABO/D typing, phenotyping, advanced phenotyping and IAT.


Picto Infectious diseases

Infectious diseases

Innobiochips is at the forefront of developing high-resolution multiplex assays that are revolutionizing infectious disease diagnostics. In particular, our team has developed the most advanced COVID-19 diagnostic tool based on its proprietary technology: Covidiag.


Picto Microbiota


Advances in molecular biology have revealed the intricate relationship between the microbiota and various diseases, providing unprecedented opportunities for novel diagnostic solutions. Innobiochips' high-resolution multiplexed diagnostic technologies can detect and characterize anti-microbiota antibodies, providing accurate and valuable insights into an individual's health status.



All the news